[New aspects of therapy of mucoviscidosis (CF)].
The authors survey of recent advances in CF research and their therapeutic implications: 1. the possibility of successful gene therapy by transfer of the normal gene to airway epithelial cells. 2. inhalations with the potassium-sparing diuretic amiloride that diminish the viscosity of the bronchial secretions, 3. application of adenosine or uridine triphosphate (ATP or UTP) to the apical surface of the respiratory epithelial cells which intervene with the function of ion channels, 4. enzymatic cleavage and liquidification of bronchial secretions by aerosolized human recombinante DNase. In addition, the possible advantages of (heart-) lung-transplantation are also discussed.
Dietzsch
H J
HJ
Klinik und Poliklinik für Kinderheilkunde, Medizinischen Akademie Carl Gustav Carus, Dresden.
Wunderlich
P
P
D000255:Adenosine Triphosphate / Q000008:administration & dosage; D000280:Administration, Inhalation; D000584:Amiloride / Q000008:administration & dosage; D002648:Child; D003550:Cystic Fibrosis / Q000235:genetics / Q000628:therapy*; D003851:Deoxyribonucleases / Q000008:administration & dosage; D015316:Genetic Therapy; D016041:Heart-Lung Transplantation; D006801:Humans; D016040:Lung Transplantation; D014544:Uridine Triphosphate / Q000008:administration & dosage
D000584:Amiloride; D000255:Adenosine Triphosphate; D003851:Deoxyribonucleases; D014544:Uridine Triphosphate
Neue Aspekte für die Therapie der Mukoviszidose (CF).